Mani Inc
TSE:7730

Watchlist Manager
Mani Inc Logo
Mani Inc
TSE:7730
Watchlist
Price: 1 156 JPY -0.43% Market Closed
Market Cap: 113.9B JPY
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one Mani Inc stock under the Base Case scenario is 1 388 JPY. Compared to the current market price of 1 156 JPY, Mani Inc is Undervalued by 17%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
1 388 JPY
Undervaluation 17%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

3.9
P/S
P/S
Price to Sales
3.9
vs History
98
vs Industry
27
Median 3Y
7.6
Median 5Y
8.3
Industry
2.2
Forward
3.7
More Details
18.9
P/E
P/E
Price to Earnings
18.9
vs History
98
vs Industry
27
Median 3Y
31
Median 5Y
33.6
Industry
21.8
Forward
17.4
More Details
15.8
P/OCF
P/OCF
Price to OCF
15.8
vs History
98
vs Industry
23
Median 3Y
24.1
Median 5Y
25.4
Industry
13.4
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
0
Median 3Y
50
Median 5Y
76.8
Industry
19
More Details
2.1
P/B
P/B
Price to Book Value
2.1
vs History
98
vs Industry
33
Median 3Y
3.7
Median 5Y
3.9
Industry
2.1
More Details
3.2
EV/S
EV/S
Enterprise Value to Sales
3.2
vs History
98
vs Industry
29
Median 3Y
6.6
Median 5Y
7.3
Industry
2.3
Forward
3.1
More Details
5.1
EV/GP
EV/GP
Enterprise Value to Gross Profit
5.1
vs History
98
vs Industry
37
Median 3Y
10.6
Median 5Y
11.8
Industry
4.8
More Details
8.9
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
8.9
vs History
98
vs Industry
31
Median 3Y
17
Median 5Y
18.8
Industry
11.4
Forward
8.4
More Details
11.4
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
11.4
vs History
98
vs Industry
32
Median 3Y
21.9
Median 5Y
24.1
Industry
15.5
More Details
13.3
EV/OCF
EV/OCF
Enterprise Value to OCF
13.3
vs History
98
vs Industry
28
Median 3Y
20.9
Median 5Y
22.5
Industry
13.3
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
0
Median 3Y
43.6
Median 5Y
66.3
Industry
17.1
More Details
2.4
EV/IC
EV/IC
Enterprise Value to IC
2.4
vs History
98
vs Industry
26
Median 3Y
5.3
Median 5Y
5.7
Industry
1.8
More Details

Multiples Across Competitors

Competitors Multiples
Mani Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
JP
Mani Inc
TSE:7730
113.9B JPY 3.9 18.9 8.9 11.4
CH
Alcon AG
SIX:ALC
38.8B CHF 4.7 46.1 19.4 37
JP
Hoya Corp
TSE:7741
5.7T JPY 6.8 27.6 18.2 21.8
DK
Coloplast A/S
CSE:COLO B
163.4B DKK 6 33.5 20.7 24.4
US
Align Technology Inc
NASDAQ:ALGN
13.5B USD 3.4 32.1 15.3 18.6
UK
ConvaTec Group PLC
LSE:CTEC
5.3B GBP 3.1 36.8 208.6 341.2
US
Lantheus Holdings Inc
NASDAQ:LNTH
7B USD 4.5 22.3 12.9 14.8
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
41.3B CNY 9.3 22.3 19.2 19.2
US
Merit Medical Systems Inc
NASDAQ:MMSI
5.6B USD 4.1 46.2 21.2 36
CH
Ypsomed Holding AG
SIX:YPSN
4.7B CHF 7.6 62.7 30.3 56.8
KR
HLB Inc
KOSDAQ:028300
7.2T KRW 106.3 -78.7 -63.9 -60.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
JP
Mani Inc
TSE:7730
Average EV/EBITDA: 37.5
8.9
9%
1
CH
Alcon AG
SIX:ALC
19.4
11%
1.8
JP
Hoya Corp
TSE:7741
18.2
14%
1.3
DK
Coloplast A/S
CSE:COLO B
20.7
11%
1.9
US
Align Technology Inc
NASDAQ:ALGN
15.3
16%
1
UK
ConvaTec Group PLC
LSE:CTEC
208.6
10%
20.9
US
Lantheus Holdings Inc
NASDAQ:LNTH
12.9
23%
0.6
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
19.2
26%
0.7
US
Merit Medical Systems Inc
NASDAQ:MMSI
21.2
14%
1.5
CH
Ypsomed Holding AG
SIX:YPSN
30.3
31%
1
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -63.9 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
JP
Mani Inc
TSE:7730
Average EV/EBIT: 58.1
11.4
N/A N/A
CH
Alcon AG
SIX:ALC
37
25%
1.5
JP
Hoya Corp
TSE:7741
21.8
N/A N/A
DK
Coloplast A/S
CSE:COLO B
24.4
12%
2
US
Align Technology Inc
NASDAQ:ALGN
18.6
19%
1
UK
ConvaTec Group PLC
LSE:CTEC
341.2
22%
15.5
US
Lantheus Holdings Inc
NASDAQ:LNTH
14.8
26%
0.6
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
19.2
22%
0.9
US
Merit Medical Systems Inc
NASDAQ:MMSI
36
29%
1.2
CH
Ypsomed Holding AG
SIX:YPSN
56.8
45%
1.3
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -60.5 N/A N/A

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 249,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.